Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3.
Pianko S, Zeuzem S, Chuang WL, Foster GR, Sarin SK, Flisiak R, Lee CM, Andreone P, Piratvisuth T, Shah S, Sood A, George J, Gould M, Komolmit P, Thongsawat S, Tanwandee T, Rasenack J, Li Y, Pang M, Yin Y, Feutren G, Jacobson IM; B2202 Study Team. Pianko S, et al. Among authors: sood a. J Viral Hepat. 2012 Sep;19(9):623-34. doi: 10.1111/j.1365-2893.2012.01586.x. Epub 2012 Mar 21. J Viral Hepat. 2012. PMID: 22863266 Clinical Trial.
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin.
Foster GR, Zeuzem S, Pianko S, Sarin SK, Piratvisuth T, Shah S, Andreone P, Sood A, Chuang WL, Lee CM, George J, Gould M, Flisiak R, Jacobson IM, Komolmit P, Thongsawat S, Tanwandee T, Rasenack J, Sola R, Messina I, Yin Y, Cammarata S, Feutren G, Brown KK. Foster GR, et al. Among authors: sood a. J Viral Hepat. 2013 Apr;20(4):e115-23. doi: 10.1111/jvh.12020. Epub 2013 Feb 14. J Viral Hepat. 2013. PMID: 23490379 Clinical Trial.
Sofosbuvir plus ribavirin in treatment-naïve patients with chronic hepatitis C virus genotype 1 or 3 infection in India.
Shah SR, Chowdhury A, Mehta R, Kapoor D, Duseja A, Koshy A, Shukla A, Sood A, Madan K, Sud R, Nijhawan S, Pawan R, Prasad M, Kersey K, Jiang D, Svarovskaia E, Doehle B, Kanwar B, Subramanian M, Acharya SK, Sarin S. Shah SR, et al. Among authors: sood a. J Viral Hepat. 2017 May;24(5):371-379. doi: 10.1111/jvh.12654. Epub 2016 Dec 9. J Viral Hepat. 2017. PMID: 27933698 Clinical Trial.
Impact of compensated cirrhosis on survival in patients with acute-on-chronic liver failure.
Thanapirom K, Teerasarntipan T, Treeprasertsuk S, Choudhury A, Sahu MK, Maiwall R, Pamecha V, Moreau R, Al Mahtab M, Chawla YK, Devarbhavi H, Yu C, Ning Q, Amarapurkar D, Eapen CE, Hamid SS, Butt AS, Kim DJ, Lee GH, Sood A, Lesmana LA, Abbas Z, Shiha G, Payawal DA, Yuen MF, Chan A, Lau G, Jia J, Rahman S, Sharma BC, Yokosuka O, Sarin SK; APASL ACLF Working Party. Thanapirom K, et al. Among authors: sood a. Hepatol Int. 2022 Feb;16(1):171-182. doi: 10.1007/s12072-021-10266-8. Epub 2021 Nov 25. Hepatol Int. 2022. PMID: 34822057 Free PMC article.
Chronic hepatitis--changing trends.
Sood A, Singh P, Midha V. Sood A, et al. J Assoc Physicians India. 1998 May;46(5):454-9. J Assoc Physicians India. 1998. PMID: 11273290 Review.
Acute variceal bleeding portends poor outcomes in patients with acute-on-chronic liver failure: a propensity score matched study from the APASL ACLF Research Consortium (AARC).
Sharma S, Agarwal S, Saraya A, Choudhury A, Mahtab MA, Alam MS, Saigal S, Kim DJ, Eapen CE, Goel A, Ning Q, Devarbhavi H, Singh V, Shukla A, Hamid S, Hu J, Tan SS, Arora A, Sahu MK, Rela M, Jothimani D, Rao PN, Kulkarni A, Ghaznian H, Lee GH, Zhongping D, Sood A, Goyal O, Lesmana LA, Lesmana RC, Treeprasertsuk S, Yuemin N, Shah S, Tao H, Dayal VM, Shaojie X, Karim F, Abbas Z, Sollano JD, Kalista KF, Shreshtha A, Payawal D, Omata M, Sarin SK; APASL ACLF Research Consortium (AARC) for APASL ACLF Working Party. Sharma S, et al. Among authors: sood a. Hepatol Int. 2022 Oct;16(5):1234-1243. doi: 10.1007/s12072-022-10372-1. Epub 2022 Jul 18. Hepatol Int. 2022. PMID: 35851437
3,238 results